title: Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine.
abstract: BHK-21 c13 monolayer and suspension cells were investigated with regard to some phenotypic features which could bear on the quality of foot-and-mouth disease virus (FMDV) antigen produced in them. Despite good viability, suspension cells differed from monolayer cells in fundamental features of susceptibility to FMDV. Most important, FMD virus particles grown in suspension cells at high passage levels were shown to be largely degraded following inactivation with an aziridine compound. Suspension cells were characterised by a downregulation in the surface expression of both alpha 5 and alpha V integrin chains. According to the results of binding assays, both integrins could act as FMDV receptors on BHK-21 c13 cells. Reduced surface expression of integrins was correlated with disappearance of actin stress fibres, which would play a role in regular encapsidation of viral RNA and hence in stability of virus particles. With regard to FMD vaccine production, practical suggestions are put forward to evaluate the quality of BHK-21 c13 cells and FMDV Ag, which must prove stable during downstream processing.
authors.affiliation: Istituto Zooprofilattico Sperimentale, Department of Vaccine Research and Development, Brescia, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Amadori
authors.forename: G
authors.initials: G
authors.lastname: Volpe
authors.forename: P
authors.initials: P
authors.lastname: Defilippi
authors.forename: C
authors.initials: C
authors.lastname: Berneri
mesh_terms: D000818:Animals; D005537:Aphthovirus; D002460:Cell Line / Q000166:cytology* / Q000378:metabolism / Q000648:ultrastructure / Q000821:virology; D006224:Cricetinae; D016023:Integrins / Q000096:biosynthesis; D007668:Kidney / Q000166:cytology; D010641:Phenotype; D013678:Technology, Pharmaceutical; D014614:Vaccines, Synthetic / Q000096:biosynthesis; D014765:Viral Vaccines / Q000096:biosynthesis*
chemical_list: D016023:Integrins; D014614:Vaccines, Synthetic; D014765:Viral Vaccines